The cost associated with administering risperidone long-acting injections in the Australian community
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The cost associated with administering risperidone long-acting injections in the Australian community ; volume:11 ; number:1 ; day:26 ; month:9 ; year:2011 ; pages:1-9 ; date:12.2011
BMC health services research ; 11, Heft 1 (26.9.2011), 1-9, 12.2011
- Creator
-
Dalton, Andrew
- Contributor
-
Lambert, Tim
Schrover, Rudolf
Hertel, Judy
Smith, Dell Kingsford
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-11-236
- URN
-
urn:nbn:de:1111-2016072134309
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dalton, Andrew
- Lambert, Tim
- Schrover, Rudolf
- Hertel, Judy
- Smith, Dell Kingsford
- SpringerLink (Online service)
Other Objects (12)
Long-Acting Reversible Contraception
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Creation of a long-acting nanoformulated dolutegravir
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Long-Acting Reversible Contraception
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Creation of a long-acting nanoformulated dolutegravir
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Long-Acting Reversible Contraception
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Creation of a long-acting nanoformulated dolutegravir
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD